ESMO 2012 News

Welcome to ESMO 2012 news. Here you will find a selection of articles that appeared in the ESMO 2012 newspaper, Congress Daily, which was distributed to attendees of the ESMO congress in Vienna.

Complete copies of the four newspapers are available for download as PDF files


Date Title Topic
01 Oct 2012 A step forward in personalised medicine in breast cancer Breast cancer
01 Oct 2012 Bone treatments: What to use and when Genitourinary cancers
01 Oct 2012 PM01183: A promising new drug for ovarian cancer Genitourinary cancers
01 Oct 2012 Successes and failures: Do targeted therapies live up to their promise? Anticancer agents & Biologic therapy
01 Oct 2012 Adding cetuximab to adjuvant chemotherapy offers no benefit to patients with resected stage III colon cancer Gastrointestinal cancers
01 Oct 2012 Continuation of bevacizumab beyond progression improves outcome in patients with metastatic colorectal cancer Gastrointestinal cancers
01 Oct 2012 PHARE trial results comparing 6 to 12 months of adjuvant trastuzumab in early breast cancer Breast cancer
01 Oct 2012 New trial results on pazopanib have important implications for patients with advanced renal cell carcinoma Gastrointestinal cancers
01 Oct 2012 How to hunt for a primary tumour site Personalised medicine
01 Oct 2012 Education Sessions: Key learning points from Sunday Palliative and supportive care - Haematologic malignancies
01 Oct 2012 New weapons in the fight against cancer
30 Sep 2012 EXPAND study shows no benefit from adding cetuximab to the first-line chemotherapy in advanced gastric cancer Gastrointestinal cancers
30 Sep 2012 Case for including patients with brain metastases in clinical trials Head and neck cancers
30 Sep 2012 ARADES: A first-in-man study of ODM-201 Genitourinary cancers
30 Sep 2012 Patient rights and obligations Bioethics, legal and economic issues